Clinical efficacy of polycaprolactone β-calcium triphosphate composite for osteoconduction in rabbit bone defect model

Chiu Ming Chen, Shen Mao Chen, Shiou Fu Lin, Huang Chien Liang, Chia Chun Wu

研究成果: 雜誌貢獻文章同行評審

5 引文 斯高帕斯(Scopus)

摘要

The combination of β-tricalcium phosphate (β-TCP) with polycaprolactone (PCL) has been considered a promising strategy for designing scaffolds for bone grafting. This study incorporated PCL with commercially available β-TCP (Osteocera™) to fabricate an injectable bone substitute and evaluate the effect of PCL on compressive strength and setting time of the hydraulic cement. The mechanical testing was compliant with the ASTM D695 and ASTM C191-13 standards. Results showed that PCL-TCP composite presented a well-defined architecture with uniform pore distribution and a significant increase in compressive strength compared with β-TCP alone. Eighteen rabbits, each with two surgically created bone defects, were treated using the PCL-TCP composites. The composite materials were resorbed and replaced by newly formed bone tissue. Both PCL-TCP and β-TCP demonstrated equivalent clinical effects on osteoconduction property in terms of the percentage of newly formed bone area measured by histomorphometric analysis. PCL-TCP was proven to be as effective as the commercially available β-TCP scaffold (Osteocera™).

原文英語
文章編號2552
期刊Polymers
13
發行號15
DOIs
出版狀態已發佈 - 8月 2021

ASJC Scopus subject areas

  • 一般化學
  • 聚合物和塑料

指紋

深入研究「Clinical efficacy of polycaprolactone β-calcium triphosphate composite for osteoconduction in rabbit bone defect model」主題。共同形成了獨特的指紋。

引用此